Samantha McLemore - Patient Capital Management,
Holding/activity history for Ovintiv Inc. (OVV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 2.05 | SEC | ||
| 2023 Q3 | 730,990 | 2.05 | Reduce 43.64% | 1.20 | $47.57 | $34,773,213 | SEC |
| 2023 Q2 | 1,297,094 | 2.75 | Add 468.15% | 2.27 | $38.07 | $49,380,360 | SEC |
| 2023 Q1 | 228,300 | 3.70 | Reduce 8.83% | 0.55 | $36.08 | $8,237,064 | SEC |
| 2022 Q4 | 250,400 | 6.27 | Reduce 2.91% | 0.18 | $50.71 | $12,697,784 | SEC |
| 2022 Q3 | 257,900 | 6.02 | Reduce 1.56% | 0.09 | $46.00 | $11,863,000 | SEC |
| 2022 Q2 | 262,000 | 5.68 | Reduce 1.58% | 0.09 | $44.19 | $11,578,000 | SEC |
| 2022 Q1 | 266,200 | 5.68 | Reduce 1.62% | 0.06 | $54.07 | $14,393,000 | SEC |
| 2021 Q4 | 270,575 | 3.69 | $33.70 | $9,118,000 | SEC |